Less educated and older patients have reduced access to biologic DMARDs even in a country with highly developed social welfare (Norway): results from Norwegian cohort study NOR-DMARD

Author(s):
Putrik, P.; Ramiro, S.; Lie, E.; Keszei, A.P.; Kvien, T.K.; Heijde, D. van der; Landewe, R.; Uhlig, T.; Boonen, A.
Published
2016
Publication type
Article / Letter to editor
rheumatic diseasesepidemiologybiological therapieshealth policiesattitude of health professionals
Date issued
2016-07-31
Language
English
Is part of
Rheumatology (2016), Vol. 55, no. 7, p. 1217-1224
hdl
1887/112338
doi
10.1093/rheumatology/kew048